查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1433616

全球口服固体製剂(OSD)契约製造市场规模、份额、趋势分析报告：按产品类型、机制、最终用途、地区和细分市场进行预测 (2024-2030)

Oral Solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report By Product Type (Tablets, Capsules, Powders, Granules), By Mechanism, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 193 Pages | 商品交期: 2-10个工作天内

价格

口服固体製剂（OSD）契约製造市场的成长与趋势：

预计2030年，全球口服固体製剂契约製造市场规模将达547亿美元，2024年至2030年复合年增长率为5.97%。新药分子复杂性的增加、领先的 CMO 和 CDMO 的研发投资以及对新治疗方法的需求不断增长是推动市场成长的关键因素。

口服固态是製药领域广泛接受的剂型，因为它们具有成本效益、易于製造且对患者友好。此外，控释和缓释性製剂等药物传递技术的进步使口服固态能够实现更高水平的生物有效性，同时减少给药频率。预计这将推动市场成长潜力。

口服固体製剂开发和大规模生产的技术进步是支持这些产品快速商业化的关键因素之一。目前市面上有多种剂型。然而，营养补充和製药食品一直致力于开发 OSD 剂型。原因在于操作简单、服用方便、病人顺从性佳。 OSD 配方技术和材料的进步预计将推动对这些配方的需求。

此外，CMO 和 CDMO 的研发投资有助于增强製造流程、配方开发和分析技术的创新。这可能会导致在口服固体製剂的生产中采用更有效和更先进的製造技术。研发投资还可以提高製造能力并扩充性。这将使 CMO 和 CDMO 能够提供更大量的口服固体製剂，以满足製药公司日益增长的需求。

此外，2023 年该行业也见证了许多策略倡议，包括联盟、合作伙伴关係、併购和服务扩张。

  • 2023年7月，Aenova集团与Galvita建立策略伙伴关係，以改善口服製剂、生产和开发。
  • 2023 年 4 月，Aenova 投资约 2,196 万美元（2,000 万欧元）扩建位于蒂特莫宁的散装固态工厂，提高产能。
  • 2023 年 1 月，Catalent 和 Ethicann 合作使用 Catalent 的口腔崩解锭(ODT) 技术开发 Ethicann 的临床药物管道。

口服固体製剂(OSD)契约製造市场报告亮点

  • 2023年，锭剂细分市场以32.7%的销售份额占据市场主导地位。锭剂是最常见且首选的 OSD型态，因为其成本效益高、结构紧凑、易于製造且易于自我管理。对双层片剂的需求不断增加以及公司扩大配方和控制释放锭剂生产的投资预计将推动市场成长。
  • 2023年，控制释放细分市场占比最大，为52.2%。这种增长归因于口服控制释放递送系统的进步，包括用于精确药物递送的生物来源递送方法，例如圆顶片、双锭剂、肠贴剂、聚合物奈米系统和外吐小体。因此，对控释剂型的高需求预计将在不久的将来推动该部门的收益成长。
  • 以最终用途划分，大型企业细分市场所占份额最大，到 2023 年将达到 54.8%。固态製剂製造市场日益受到协作、弹性和高适应性的影响。越来越多的药物开发公司打算从头开始设计药物，并将委託给大型 CMO，从而加速市场成长。此外，越来越多地聘请专门从事口服固体製剂的CMO，因为他们可以为大型製药公司带来好处。
  • 预计亚太地区将在 2023 年引领全球市场，预测期内复合年增长率最快为 6.3%。中国和印度是口服固体製剂契约製造的主要国家，价格明显较低。此外，新加坡、印度和韩国等亚洲国家因其不断扩大的製造能力而被认为是製药业的主要参与者。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章口服固体製剂（OSD）契约製造市场：变数、趋势、范围

  • 市场体系展望
  • 市场动态
  • 口服固体製剂(OSD)契约製造市场：分析工具
  • COVID-19 影响分析
  • 口服固体製剂(OSD) 包装类型分析：泡壳与瓶装（体积百分比，2022 年）

第四章口服固体製剂（OSD）契约製造市场：細項分析，依产品类型（2018-2030）

  • 口服固体製剂（OSD）契约製造市场：按产品类型分類的要点
  • 口服固体製剂（OSD）契约製造市场：产品类型变化分析
  • 依产品类型

第五章口服固体製剂（OSD）契约製造市场：机制分析

  • 口服固体製剂（OSD）契约製造市场：机制要点
  • 口服固体製剂（OSD）契约製造市场：机制变化分析
  • 按机理

第六章口服固体製剂（OSD）契约製造市场：最终用途分析

  • 口服固体製剂（OSD）契约製造市场：依最终用途分類的要点
  • 口服固体製剂（OSD）契约製造市场：最终用途变化分析
  • 按最终用途

第七章口服固体製剂（OSD）契约製造市场：区域分析

  • 口服固体製剂契约製造（OSD）：市场占有率分析（2023/2030）
  • 按地区
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第八章 竞争形势

  • 公司形势
    • Richter-Helm BioLogics
    • Lonza
    • Catalent, Inc
    • Aenova Group
    • Boehringer Ingelheim International GmbH
    • Jubilant Pharmova Limited
    • Patheon Pharma Services
    • Recipharm AB.
    • Corden Pharma International
    • Siegfried Holding AG
    • Piramal Pharma Solutions
    • AbbVie Contract Manufacturing
    • Next Pharma AB
  • 公司分类
  • 产品/服务热图分析
  • 策略倡议
    • 获得
    • 合作
    • 业务扩展
    • 服务开始
    • 合伙
    • 其他的

第 9 章 要点

Product Code: GVR-4-68039-948-4

Oral Solid Dosage Contract Manufacturing Market Growth & Trends:

The global oral solid dosage contract manufacturing market size is expected to reach USD 54.7 billion by 2030 and expand at a CAGR of 5.97% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing complexity of new drug molecules, R&D investments by large CMOs & CDMOs and rising demand for novel therapies are key factors driving market growth.

Oral solids are widely accepted dosage forms in the pharmaceutical sector since they are cost-effective, simple to manufacture, and patient-friendly. Furthermore, advances in drug delivery technology, such as control release and sustained release formation, are enabling oral solids to achieve even higher levels of bioavailability while lowering drug administration frequency. Thereby, it is anticipated to propel market growth potential.

Technological advancements in the development and bulk manufacturing of oral solid dosage forms are among the primary factors supporting the fast-track commercialization of these products. Currently, a diverse array of dosage forms is accessible in the market. However, the nutraceutical and pharmaceutical industries consistently put effort into developing OSD forms. This preference is due to their ease of handling, convenient consumption, and positive patient adherence. Anticipated advancements in technology and materials of OSD forms are projected to boost the demand for these formulations.

Furthermore, R&D investments by CMOs and CDMOs contribute to enhanced innovation in manufacturing processes, formulation development, & analytical technologies. This can lead to the adoption of more efficient and advanced manufacturing techniques in the production of oral solid dosage forms. Also, investments in R&D result in the expansion of manufacturing capabilities and improved scalability. This allows CMOs and CDMOs to offer larger volumes of oral solid dosage production to meet the increasing demand from pharmaceutical companies.

Moreover, the industry witnessed many strategic movements in 2023, such as collaborations, partnerships, M&As, service expansion, etc.

  • In July 2023, Aenova Group and Galvita entered a strategic partnership to improve the formulation, production, and development of oral dosage forms.
  • In April 2023, Aenova invested approximately USD 21.96 million (20 million euros) to expand its high-volume solids site in Tittmoning, resulting in increased capacity.
  • In January 2023, Catalent and Ethicann collaborated to develop Ethicann's clinical drug pipeline using Catalent's technology known as Orally Disintegrating Tablet (ODT) technology.

Oral Solid Dosage Contract Manufacturing Market Report Highlights:

  • The tablets segment dominated the market with a revenue share of 32.7% in 2023. Tablets are the most common and preferred OSD form due to their cost-effectiveness, high compactness, easy manufacturing, and convenience of self-administration. Increased demand for bilayer tablets and investments by firms to expand formulation and controlled-release tablet manufacturing are predicted to drive market growth
  • The controlled release segment accounted for the largest share of 52.2% in 2023. This growth is attributed to advancements in oral controlled release delivery systems, including dome tablets, dual drug tablets, intestinal patches, polymer nanosystems, and bioinspired delivery methods, such as exosomes for precise drug delivery. Thus, high demand for control release dosage forms is anticipated to boost segmental revenue growth in the near future
  • Based on end-use, the large size companies segment accounted for the largest share of 54.8% in 2023. The solid dose manufacturing market is increasingly defined by collaboration, flexibility, and high adaptability. More pharma developers design drugs from the start, intending to outsource them to large CMOs, thereby accelerating market growth. Furthermore, CMOs specializing in oral solid dosage can provide several benefits to large pharmaceutical companies, leading to their increased adoption
  • Asia Pacific led the global market in 2023 and is projected to witness the fastest CAGR of 6.3% during the forecast years. China and India are the powerhouses of oral solid dosage contract manufacturing organizations with significantly lower prices. Further, expanding manufacturing capabilities among Asian countries such as Singapore, India, and South Korea have been considered major players in the pharmaceutical industry due to their expanding manufacturing capabilities

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Regional Scope
    • 1.1.2 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
    • 1.5.1 Region Wise Market Calculation
    • 1.5.2 Region Wise Market: Base Estimates
    • 1.5.3 Global Market: Cagr Calculation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
    • 1.6.2 Value-Chain-Based Sizing & Forecasting (Model 2)
    • 1.6.3 Qfd Model Sizing & Forecasting (Model 3)
  • 1.7 Market Formulation & Validation
  • 1.8 Market Definitions/Scope
  • 1.9 List Of Secondary Sources
  • 1.10 List Of Primary Sources
  • 1.11 List Of Abbreviations
  • 1.12 Objectives
    • 1.12.1 Objective - 1
    • 1.12.2 Objective - 2
    • 1.12.3 Objective - 3
    • 1.12.4 Objective - 4

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Segment Snapshot
  • 2.4 Competitive Landscape Snapshot

Chapter 3 Oral Solid Dosage Contract Manufacturing Market: Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
      • 3.2.1.1 Technological Advancements In Oral Solid Dosage (Osd) Forms
      • 3.2.1.2 Expansion Of Manufacturing Capacity By Cmos & Cdmos For Osd
      • 3.2.1.3 Increasing Demand For Novel Therapies
      • 3.2.1.4 Increasing Demand For One-Stop-Shop Cdmos
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 Strict Approval Criteria By Regulatory Authorities
      • 3.2.2.2 Lack Of Experienced Technical Staff, Physical Capability, And Equipment Capacity
      • 3.2.2.3 Increasing Need For Biosimilars And Their Prominence In Addressing Cancer & Other Medical Conditions
  • 3.3 Oral Solid Dosage Contract Manufacturing Market: Analysis Tools
    • 3.3.1 Porter's Five Forces Analysis
    • 3.3.2 Pestel Analysis
  • 3.4 Covid-19 Impact Analysis
  • 3.5 Analysis Pertaining To Oral Solid Dosage Packaging Types, By Blisters Vs. Bottles (Volume % Share, 2022)
    • 3.5.1 Blister Packaging
    • 3.5.2 Bottle Packaging
    • 3.5.3 Types Of Blister Packaging
    • 3.5.4 Blister Packaging

Chapter 4 Oral Solid Dosage Contract Manufacturing Market: Segment Analysis, By Product Type, 2018 - 2030 (USD Million)

  • 4.1 Oral Solid Dosage Contract Manufacturing Market By Product Type: Key Takeaways
  • 4.2 Oral Solid Dosage Contract Manufacturing Market: Product Type Movement Analysis
  • 4.3 Oral Solid Dosage Contract Manufacturing Market Estimates & Forecasts By Product Type (USD Million)
    • 4.3.1 Tablets
      • 4.3.1.1 Tablets Oral Solid Dosage Contract Manufacturing Market, 2018 - 2030 (USD Million)
    • 4.3.2 Capsules
      • 4.3.2.1 Capsules Oral Solid Dosage Contract Manufacturing Market, 2018 - 2030 (USD Million)
    • 4.3.3 Powders
      • 4.3.3.1 Powders Oral Solid Dosage Contract Manufacturing Market, 2018 - 2030 (USD Million)
    • 4.3.4 Granules
      • 4.3.4.1 Granules Oral Solid Dosage Contract Manufacturing Market, 2018 - 2030 (USD Million)
    • 4.3.5 Others
      • 4.3.5.1 Others Oral Solid Dosage Contract Manufacturing Market, 2018 - 2030 (USD Million)

Chapter 5 Oral Solid Dosage Contract Manufacturing Market: Mechanism Analysis

  • 5.1 Oral Solid Dosage Contract Manufacturing Market By Mechanism Segment: Key Takeaways
  • 5.2 Oral Solid Dosage Contract Manufacturing Market: Mechanism Movement Analysis
  • 5.3 Oral Solid Dosage Contract Manufacturing Market Estimates & Forecasts By Mechanism (USD Million)
    • 5.3.1 Immediate Release (IR)
      • 5.3.1.1 Immediate Release Contract Manufacturing Market, 2018 - 2030 (USD Million)
    • 5.3.2 Delayed Release
      • 5.3.2.1 Delayed Release Contract Manufacturing Market, 2018 - 2030 (USD Million)
    • 5.3.3 Controlled Release (CR)
      • 5.3.3.1 Controlled Release Contract Manufacturing Market, 2018 - 2030 (USD Million)

Chapter 6 Oral Solid Dosage Contract Manufacturing Market: End-Use Analysis

  • 6.1 Oral Solid Dosage Contract Manufacturing Market, By End-Use Segment: Key Takeaways
  • 6.2 Oral Solid Dosage Contract Manufacturing Market: End-Use Movement Analysis
  • 6.3 Oral Solid Dosage Contract Manufacturing Market Estimates & Forecasts By End-Use (USD Million)
    • 6.3.1 Large-Size Companies
      • 6.3.1.1 Large-Size Companies Contract Manufacturing Market, 2018 - 2030 (USD Million)
    • 6.3.2 Medium- & Small-Size Companies
      • 6.3.2.1 Medium- & Small- Sized Companies Contract Manufacturing Market, 2018 - 2030 (USD Million)
    • 6.3.3 Others
      • 6.3.3.1 Others Contract Manufacturing Market, 2018 - 2030 (USD Million)

Chapter 7 Oral Solid Dosage Contract Manufacturing Market: Regional Analysis

  • 7.1 Oral Solid Dosage Contract Manufacturing: Market Share Analysis, 2023 & 2030
  • 7.2 Oral Solid Dosage Contract Manufacturing: Market Estimates And Forecasts, By Region (USD Million)
  • 7.3 North America
    • 7.3.1 North America Oral Solid Dosage Contract Manufacturing Market, 2018 - 2030 (USD Million)
    • 7.3.2 U.S.
      • 7.3.2.1 Key Country Dynamics
      • 7.3.2.2 Competitive Scenario
      • 7.3.2.3 Regulatory Scenario
      • 7.3.2.4 U.S. Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3 Canada
      • 7.3.3.1 Key Country Dynamics
      • 7.3.3.2 Competitive Scenario
      • 7.3.3.3 Regulatory Scenario
      • 7.3.3.4 Canada Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4 Europe
    • 7.4.1 Europe Oral Solid Dosage Contract Manufacturing Market, 2018 - 2030 (USD Million)
    • 7.4.2 Uk
      • 7.4.2.1 Key Country Dynamics
      • 7.4.2.2 Competitive Scenario
      • 7.4.2.3 Regulatory Scenario
      • 7.4.2.4 Uk Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3 Germany
      • 7.4.3.1 Key Country Dynamics
      • 7.4.3.2 Competitive Scenario
      • 7.4.3.3 Regulatory Scenario
      • 7.4.3.4 Germany Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4 France
      • 7.4.4.1 Key Country Dynamics
      • 7.4.4.2 Competitive Scenario
      • 7.4.4.3 Regulatory Scenario
      • 7.4.4.4 France Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5 Italy
      • 7.4.5.1 Key Country Dynamics
      • 7.4.5.2 Competitive Scenario
      • 7.4.5.3 Regulatory Scenario
      • 7.4.5.4 Italy Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6 Spain
      • 7.4.6.1 Key Country Dynamics
      • 7.4.6.2 Competitive Scenario
      • 7.4.6.3 Regulatory Scenario
      • 7.4.6.4 Spain Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7 Denmark
      • 7.4.7.1 Key Country Dynamics
      • 7.4.7.2 Competitive Scenario
      • 7.4.7.3 Regulatory Scenario
      • 7.4.7.4 Denmark Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030, (USD Million)
    • 7.4.8 Sweden
      • 7.4.8.1 Key Country Dynamics
      • 7.4.8.2 Competitive Scenario
      • 7.4.8.3 Regulatory Scenario
      • 7.4.8.4 Sweden Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030, (USD Million)
    • 7.4.9 Norway
      • 7.4.9.1 Key Country Dynamics
      • 7.4.9.2 Competitive Scenario
      • 7.4.9.3 Regulatory Scenario
      • 7.4.9.4 Norway Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030, (USD Million)
  • 7.5 Asia Pacific
    • 7.5.1 Asia Pacific Oral Solid Dosage Contract Manufacturing Market, 2018 - 2030 (USD Million
    • 7.5.2 China
      • 7.5.2.1 Key Country Dynamics
      • 7.5.2.2 Competitive Scenario
      • 7.5.2.3 Regulatory Scenario
      • 7.5.2.4 China Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3 India
      • 7.5.3.1 Key Country Dynamics
      • 7.5.3.2 Competitive Scenario
      • 7.5.3.3 Regulatory Scenario
      • 7.5.3.4 India Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4 Japan
      • 7.5.4.1 Key Country Dynamics
      • 7.5.4.2 Competitive Scenario
      • 7.5.4.3 Regulatory Scenario
      • 7.5.4.4 Japan Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5 Australia
      • 7.5.5.1 Key Country Dynamics
      • 7.5.5.2 Competitive Scenario
      • 7.5.5.3 Regulatory Scenario
      • 7.5.5.4 Australia Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6 South Korea
      • 7.5.6.1 Key Country Dynamics
      • 7.5.6.2 Competitive Scenario
      • 7.5.6.3 Regulatory Scenario
      • 7.5.6.4 South Korea Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7 Thailand
      • 7.5.7.1 Key Country Dynamics
      • 7.5.7.2 Competitive Scenario
      • 7.5.7.3 Regulatory Scenario
      • 7.5.7.4 Thailand Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6 Latin America
    • 7.6.1 Latin America Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2 Brazil
      • 7.6.2.1 Key Country Dynamics
      • 7.6.2.2 Competitive Scenario
      • 7.6.2.3 Regulatory Scenario
      • 7.6.2.4 Brazil Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3 Mexico
      • 7.6.3.1 Key Country Dynamics
      • 7.6.3.2 Competitive Scenario
      • 7.6.3.3 Regulatory Scenario
      • 7.6.3.4 Mexico Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4 Argentina
      • 7.6.4.1 Key Country Dynamics
      • 7.6.4.2 Competitive Scenario
      • 7.6.4.3 Regulatory Scenario
      • 7.6.4.4 Argentina Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030, (USD Million)
  • 7.7 MEA
    • 7.7.1 MEA Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030, (USD Million)
    • 7.7.2 South Africa
      • 7.7.2.1 Key Country Dynamics
      • 7.7.2.2 Competitive Scenario
      • 7.7.2.3 Regulatory Scenario
      • 7.7.2.4 South Africa Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030, (USD Million)
    • 7.7.3 Saudi Arabia
      • 7.7.3.1 Key Country Dynamics
      • 7.7.3.2 Competitive Scenario
      • 7.7.3.3 Regulatory Scenario
      • 7.7.3.4 Saudi Arabia Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030, (USD Million)
    • 7.7.4 UAE
      • 7.7.4.1 Key Country Dynamics
      • 7.7.4.2 Competitive Scenario
      • 7.7.4.3 Regulatory Scenario
      • 7.7.4.4 UAE Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.5 Kuwait
      • 7.7.5.1 Key Country Dynamics
      • 7.7.5.2 Competitive Scenario
      • 7.7.5.3 Regulatory Scenario
      • 7.7.5.4 Kuwait Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8 Competitive Landscape

  • 8.1. Company Landscape
    • 8.1.1. Richter-Helm BioLogics
      • 8.1.1.1. Company overview
      • 8.1.1.2. Financial performance
      • 8.1.1.3. Product benchmarking
      • 8.1.1.4. Strategic initiatives
    • 8.1.2. Lonza
      • 8.1.2.1. Company overview
      • 8.1.2.2. Financial performance
      • 8.1.2.3. Product benchmarking
      • 8.1.2.4. Strategic initiatives
    • 8.1.3. Catalent, Inc
      • 8.1.3.1. Company overview
      • 8.1.3.2. Financial performance
      • 8.1.3.3. Product benchmarking
      • 8.1.3.4. Strategic initiatives
    • 8.1.4. Lonza
      • 8.1.4.1. Company overview
      • 8.1.4.2. Financial performance
      • 8.1.4.3. Product benchmarking
      • 8.1.4.4. Strategic initiatives
    • 8.1.5. Aenova Group
      • 8.1.5.1. Company overview
      • 8.1.5.2. Financial performance
      • 8.1.5.3. Product benchmarking
      • 8.1.5.4. Strategic initiatives
    • 8.1.6. Boehringer Ingelheim International GmbH
      • 8.1.6.1. Company overview
      • 8.1.6.2. Financial performance
      • 8.1.6.3. Product benchmarking
      • 8.1.6.4. Strategic initiatives
    • 8.1.7. Jubilant Pharmova Limited
      • 8.1.7.1. Company overview
      • 8.1.7.2. Financial performance
      • 8.1.7.3. Product benchmarking
      • 8.1.7.4. Strategic initiatives
    • 8.1.8. Patheon Pharma Services
      • 8.1.8.1. Company overview
      • 8.1.8.2. Financial performance
      • 8.1.8.3. Product benchmarking
      • 8.1.8.4. Strategic initiatives
    • 8.1.9. Recipharm AB.
      • 8.1.9.1. Company overview
      • 8.1.9.2. Financial performance
      • 8.1.9.3. Product benchmarking
      • 8.1.9.4. Strategic initiatives
    • 8.1.10. Corden Pharma International
      • 8.1.10.1. Company overview
      • 8.1.10.2. Financial performance
      • 8.1.10.3. Product benchmarking
      • 8.1.10.4. Strategic initiatives
    • 8.1.11. Siegfried Holding AG
      • 8.1.11.1. Company overview
      • 8.1.11.2. Financial performance
      • 8.1.11.3. Product benchmarking
      • 8.1.11.4. Strategic initiatives
    • 8.1.12. Piramal Pharma Solutions
      • 8.1.12.1. Company overview
      • 8.1.12.2. Financial performance
      • 8.1.12.3. Product benchmarking
      • 8.1.12.4. Strategic initiatives
    • 8.1.13. AbbVie Contract Manufacturing
      • 8.1.13.1. Company overview
      • 8.1.13.2. Financial performance
      • 8.1.13.3. Product benchmarking
      • 8.1.13.4. Strategic initiatives
    • 8.1.14. Next Pharma AB
      • 8.1.14.1. Company overview
      • 8.1.14.2. Financial performance
      • 8.1.14.3. Product benchmarking
      • 8.1.14.4. Strategic initiatives
  • 8.2 Company Categorization
  • 8.3 Product/Service Heat Map Analysis
  • 8.4 Strategy Initiatives
    • 8.4.1 Acquisition
    • 8.4.2 Collaboration
    • 8.4.3 Expansion
    • 8.4.4 Service Launch
    • 8.4.5 Partnership
    • 8.4.6 Others

Chapter 9 Key Takeaways

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Oral Solid Dosage Contract Manufacturing market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 4 North America Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 5 North America Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 U.S. Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 7 U.S. Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 8 U.S. Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Canada Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 10 Canada Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 11 Canada Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe Oral Solid Dosage Contract Manufacturing market, by region, 2018 - 2030 (USD Million)
  • Table 13 Europe Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 14 Europe Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 15 Europe Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 UK Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 17 UK Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 18 UK Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Germany Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 20 Germany Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 21 Germany Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 France Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 23 France Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 24 France Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Italy Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 26 Italy Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 27 Italy Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Spain Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 29 Spain Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 30 Spain Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Denmark Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 32 Denmark Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 33 Denmark Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Sweden Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 35 Sweden Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 36 Sweden Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Norway Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 38 Norway Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 39 Norway Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific Oral Solid Dosage Contract Manufacturing market, by region, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 China Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 45 China Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 46 China Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 India Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 48 India Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 49 India Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Japan Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million) 2018 - 2030
  • Table 51 Japan Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 52 Japan Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Australia Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 54 Australia Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 55 Australia Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 South Korea Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 57 South Korea Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 58 South Korea Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Thailand Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 60 Thailand Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 61 Thailand Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Latin America Oral Solid Dosage Contract Manufacturing market, by region, 2018 - 2030 (USD Million)
  • Table 63 Latin America Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 64 Latin America Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 65 Latin America Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Brazil Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million) 2018 - 2030
  • Table 67 Brazil Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 68 Brazil Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Mexico Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 70 Mexico Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 71 Mexico Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 72 Argentina Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 73 Argentina Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 74 Argentina Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 MEA Oral Solid Dosage Contract Manufacturing market, by region, 2018 - 2030 (USD Million)
  • Table 76 MEA Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 77 MEA Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 78 MEA Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 South Africa Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 80 South Africa Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 81 South Africa Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 UAE Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 86 UAE Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 87 UAE Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
  • Table 90 Kuwait Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Oral solid dosage contract manufacturing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Value-Chain-Based Sizing & Forecasting
  • Fig. 9 QFD model sizing & forecasting
  • Fig. 10 Market formulation & validation
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Segment snapshot
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 Parent market outlook, 2023 (USD Million)
  • Fig. 16 Ancillary market outlook, 2023 (USD Million)
  • Fig. 17 Oral solid dosage contract manufacturing market dynamics
  • Fig. 18 Biosimilar approval in the U.S. and EU per year (2016 - 2021)
  • Fig. 19 Porter's five forces analysis
  • Fig. 20 PESTEL analysis
  • Fig. 21 Oral solid dosage packaging types in the U.S., 2023 (volume percentage share %)
  • Fig. 22 Oral solid dosage blister packaging types in the U.S., 2023 (volume percentage share %)
  • Fig. 23 Oral solid dosage contract manufacturing market: Product type outlook and key takeaways
  • Fig. 24 Oral solid dosage contract manufacturing market: Product type movement analysis
  • Fig. 25 Tablets oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 26 Capsules oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 27 Powders oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 28 Granules oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 29 Others oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 30 Oral solid dosage contract manufacturing market: Mechanism outlook and key takeaways
  • Fig. 31 Oral solid dosage contract manufacturing market: Mechanism movement analysis
  • Fig. 32 Immediate release contract manufacturing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 33 Delayed release contract manufacturing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 34 Controlled release contract manufacturing market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 35 Oral solid dosage contract manufacturing market: End-use outlook and key takeaways
  • Fig. 36 Oral solid dosage contract manufacturing market: End-use movement analysis
  • Fig. 37 Large-size companies market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 38 Medium- & small- sized companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Others market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 40 Regional market: Key takeaways
  • Fig. 41 Regional outlook, 2023 & 2030
  • Fig. 42 Regional outlook, 2023 & 2030
  • Fig. 43 North America market, 2018 - 2030 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 U.S. Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Canada Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Europe Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 UK Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Germany Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 France Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Italy Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Spain Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Denmark Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Sweden Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Norway Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Asia Pacific Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 China Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Regulatory bodies in India involved in pharmaceutical regulations
  • Fig. 70 India Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Clinical trial authorization process in Japan
  • Fig. 73 Clinical Research of Medical Products in Japan
  • Fig. 74 Japan Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 78 Australia Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Clinical trial approval process in South Korea
  • Fig. 81 South Korea Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Thailand Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Latin America Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Brazil Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Mexico Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Argentina Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 MEA Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 South Africa Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Saudi Arabia Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 Clinical trial authorization process UAE
  • Fig. 98 UAE Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 Kuwait Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Key company categorization
  • Fig. 102 Product/service heat map analysis